Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 2/2021

18.01.2021 | Interesting image

False-Positive Gallium-68 DOTATATE PET/CT in Vertebral Hemangioma

verfasst von: Ahmed Abdulrahman Alruwaili, Alaa Khalid Alduraibi, Mohammed Fahed Alzayed

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

A healthy 52-year-old man started to have few minutes spells of palpitation, tachycardia, hot flashes, and chest tightness. He had a lab work-up for carcinoid, including 5-hydroxyindoleacetic acid (5-HIAA), which was negative. Months later, his symptoms became worse which warranted further investigation to exclude carcinoid disease. Gallium-68 DOTATATE positron emission tomography combined with computed tomography (PET/CT) scanning was performed to assess the patient for carcinoid tumor. It showed foci of radiotracer avidity in the thoracic and lumber spine. Magnetic resonance imaging (MRI) for the vertebral lesions showed atypical hemangioma. Subsequently, follow-up serum chromogranin A testing was negative.
Literatur
1.
Zurück zum Zitat Krenning EP, Breeman WA, Kooij PP, Lameris JS, Bakker WH, Koper JW, et al. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989;333:242–4.CrossRef Krenning EP, Breeman WA, Kooij PP, Lameris JS, Bakker WH, Koper JW, et al. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet. 1989;333:242–4.CrossRef
2.
Zurück zum Zitat Vanhagen PM, Krenning EP, Reubi JC, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med. 1994;21:497Y502.CrossRef Vanhagen PM, Krenning EP, Reubi JC, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med. 1994;21:497Y502.CrossRef
3.
Zurück zum Zitat Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985;79:339–54.CrossRef Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985;79:339–54.CrossRef
4.
Zurück zum Zitat Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer. 2005;12:1083–92.CrossRef Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer. 2005;12:1083–92.CrossRef
5.
Zurück zum Zitat Skoura E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, Al Harbi M, Toumpanakis C, et al. The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United Kingdom. J Nucl Med. 2016;57:34–40.CrossRef Skoura E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, Al Harbi M, Toumpanakis C, et al. The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United Kingdom. J Nucl Med. 2016;57:34–40.CrossRef
6.
Zurück zum Zitat Albanus DR, Apitzsch J, Erdem Z, Erdem O, Verburg FA, Behrendt FF, et al. Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET). Eur J Radiol. 2015;84:1866–72.CrossRef Albanus DR, Apitzsch J, Erdem Z, Erdem O, Verburg FA, Behrendt FF, et al. Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET). Eur J Radiol. 2015;84:1866–72.CrossRef
7.
Zurück zum Zitat Putzer D, Gabriel M, Henninger B, et al. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA- Tyr3-octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med. 2009:1214–21. Putzer D, Gabriel M, Henninger B, et al. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA- Tyr3-octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med. 2009:1214–21.
8.
Zurück zum Zitat Kroiss A, Putzer D, Decristoforo C, Uprimny C, Warwitz B, Nilica B, et al. 68 Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT. Eur J Nucl Med. 2013;40:514–23.CrossRef Kroiss A, Putzer D, Decristoforo C, Uprimny C, Warwitz B, Nilica B, et al. 68 Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT. Eur J Nucl Med. 2013;40:514–23.CrossRef
9.
Zurück zum Zitat Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. QJ Nucl Med Mol Imag. 2010;54:61–7. Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. QJ Nucl Med Mol Imag. 2010;54:61–7.
10.
Zurück zum Zitat Skoura E, Alshammari A, Syed R, Sajjan R, Bomanji J. Adolescent with 68Ga DOTATATE-avid vertebral hemangioma mimicking metastasis in PET imaging. Clin Nucl Med. 2015;40:e378–9.CrossRef Skoura E, Alshammari A, Syed R, Sajjan R, Bomanji J. Adolescent with 68Ga DOTATATE-avid vertebral hemangioma mimicking metastasis in PET imaging. Clin Nucl Med. 2015;40:e378–9.CrossRef
11.
Zurück zum Zitat Gauthé M, Dardel NT, Santiago FR, Ohnona J, Nataf V, Montravers F, et al. Vertebral metastases from neuroendocrine tumours: how to avoid false positives on 68 Ga-DOTA-TOC PET using CT pattern analysis? Eur Radiol. 2018;28:3943–52.CrossRef Gauthé M, Dardel NT, Santiago FR, Ohnona J, Nataf V, Montravers F, et al. Vertebral metastases from neuroendocrine tumours: how to avoid false positives on 68 Ga-DOTA-TOC PET using CT pattern analysis? Eur Radiol. 2018;28:3943–52.CrossRef
Metadaten
Titel
False-Positive Gallium-68 DOTATATE PET/CT in Vertebral Hemangioma
verfasst von
Ahmed Abdulrahman Alruwaili
Alaa Khalid Alduraibi
Mohammed Fahed Alzayed
Publikationsdatum
18.01.2021
Verlag
Springer Singapore
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 2/2021
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-021-00682-x

Weitere Artikel der Ausgabe 2/2021

Nuclear Medicine and Molecular Imaging 2/2021 Zur Ausgabe